SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neuren Pharmaceuticals Shares Gain on Upbeat FY Trofinetide Outlook

Neuren Pharmaceuticals shares gained on an upbeat full-year outlook for trofinetide earnings.

Related stories